Zajkowska, M.; Dulewicz, M.; Kulczyńska-Przybik, A.; Safiejko, K.; Juchimiuk, M.; Konopko, M.; Kozłowski, L.; Mroczko, B.
The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients. J. Clin. Med. 2022, 11, 1794.
https://doi.org/10.3390/jcm11071794
AMA Style
Zajkowska M, Dulewicz M, Kulczyńska-Przybik A, Safiejko K, Juchimiuk M, Konopko M, Kozłowski L, Mroczko B.
The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients. Journal of Clinical Medicine. 2022; 11(7):1794.
https://doi.org/10.3390/jcm11071794
Chicago/Turabian Style
Zajkowska, Monika, Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Kamil Safiejko, Marcin Juchimiuk, Marzena Konopko, Leszek Kozłowski, and Barbara Mroczko.
2022. "The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients" Journal of Clinical Medicine 11, no. 7: 1794.
https://doi.org/10.3390/jcm11071794
APA Style
Zajkowska, M., Dulewicz, M., Kulczyńska-Przybik, A., Safiejko, K., Juchimiuk, M., Konopko, M., Kozłowski, L., & Mroczko, B.
(2022). The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients. Journal of Clinical Medicine, 11(7), 1794.
https://doi.org/10.3390/jcm11071794